ArticleEye (London, England)2021

The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.

Ayşegül Çömez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.